New Stock Addition: High Quality Healthcare Company Trading at an Extremely Cheap Valuation
We Are Buyers of This High Quality Healthcare Stock Ahead of Tomorrow's Earnings.
We are adding this stock to the Aurelion Index today.
We are adding the stock to the Aurelion Index before tomorrow’s earnings. The stock has continued to decrease, and we believe this makes it an amazing entry point into this high-quality compounder.
After discussions with IQVIA researchers, we have confidence in the company’s moat and strong competitive positioning.
We were waiting to initiate after our meeting with management, but the setup is too compelling not to buy before earnings. A full deep dive will come later for our paid subscribers. We believe this is a company set to compound over the next five years, and it also represents a compelling opportunity.
In a few words, this is what we like about the company:
Long runway for revenue growth above 10%
Specialized player with a clear moat
Visibility into margin expansion and inflection point in cash generation
Overstated impact of GLP-1s
Extremely attractive entry point ahead of earnings
Table of Contents:
Company Overview
Investment Thesis
Why We are Buying Now Before Earnings